Picton Mahoney Asset Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-580
Closed -$16K 853
2024
Q3
$16K Buy
+580
New +$14.5K ﹤0.01% 494
2023
Q1
Sell
-1,590
Closed -$19K 512
2022
Q4
$19K Hold
1,590
﹤0.01% 565
2022
Q3
$15K Sell
1,590
-200
-11% -$2.42K ﹤0.01% 615
2022
Q2
$18K Sell
1,790
-84,010
-98% -$1.7M ﹤0.01% 708
2022
Q1
$2.96M Buy
85,800
+50,100
+140% +$1.63M 0.1% 252
2021
Q4
$1.78M Buy
+35,700
New +$1.88M 0.04% 452

Other funds holding ASPN

Picton Mahoney Asset Management's ASPN Position: Q4 2024 in Review

Picton Mahoney Asset Management sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 580 shares — an estimated $16K sold.

Picton Mahoney Asset Management first reported a position in ASPN in Q4 2021 and held it in 6 quarters. The position peaked at $2.96M in Q1 2022. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Picton Mahoney Asset Management reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 580 Aspen Aerogels shares in Q4 2024, an estimated $16K.
  • Picton Mahoney Asset Management first reported a position in Aspen Aerogels in Q4 2021 and held it in 6 quarters.
  • Picton Mahoney Asset Management's Aspen Aerogels position peaked at $2.96M in Q1 2022.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.